Omega-6, Arachidonic Acid

Arachidonic acid (AA) is a 20-carbon omega-6 polyunsaturated fatty acid that is a fundamental structural component of cell membranes throughout the body. It is stored mainly within membrane phospholipids and is especially concentrated in tissues with high metabolic and signaling activity, including the brain, muscles, liver, and immune cells. Your body obtains arachidonic acid in two ways: directly from food (particularly animal-derived foods) and indirectly by converting linoleic acid, an essential omega-6 fatty acid found in many plant oils, nuts, and seeds.

AA plays a central biological role because it serves as the precursor for a large family of signaling molecules known as eicosanoids. When cells are stimulated by injury, infection, or stress, arachidonic acid is released from cell membranes by the enzyme phospholipase A₂. Once freed, it is rapidly converted into prostaglandins, thromboxanes, leukotrienes, and lipoxins through enzymatic pathways involving cyclooxygenase (COX) and lipoxygenase (LOX) enzymes. These compounds act locally and transiently to regulate inflammation, blood flow, platelet aggregation, immune cell activation, and pain signaling.

Importantly, arachidonic acid is not inherently “bad.” Acute inflammation driven by AA-derived mediators is essential for wound healing, immune defense, and tissue repair. AA also contributes to normal brain development, neurotransmission, muscle contraction, and cellular membrane fluidity, allowing receptors and enzymes to function correctly. Problems arise not from arachidonic acid itself, but from excessive or poorly balanced production of AA-derived mediators, particularly when omega-6 intake greatly exceeds omega-3 intake and resolution pathways are insufficient.

Arachidonic acid matters because it sits at the crossroads of inflammation, immunity, vascular function, and cellular communication. Its metabolites help orchestrate the body’s immediate response to injury or infection by increasing blood flow, recruiting immune cells, and activating platelets. These actions are essential for survival. However, when arachidonic-acid-derived signaling remains chronically elevated, it can contribute to persistent low-grade inflammation—a recognized driver of many chronic diseases.

In cardiovascular health, AA-derived thromboxanes and prostaglandins influence platelet aggregation, blood vessel tone, and clot formation. Elevated AA activity has been linked to increased risk of atherothrombosis, particularly when combined with other risk factors such as insulin resistance, elevated LDL cholesterol, smoking, or poor omega-3 status. Inflammatory AA metabolites can also promote endothelial dysfunction, a key early step in atherosclerosis.

In metabolic health, excessive arachidonic-acid-driven inflammation has been associated with insulin resistance, fatty liver disease, and obesity-related metabolic dysfunction. AA-derived eicosanoids can influence adipose tissue inflammation, liver enzyme activity, and glucose metabolism, contributing to cardiometabolic risk when regulation is impaired.

Arachidonic acid is also deeply involved in immune and inflammatory conditions. Elevated production of leukotrienes and prostaglandins plays a role in asthma, allergic disease, inflammatory bowel disease, arthritis, and autoimmune conditions. Conversely, AA-derived lipoxins are involved in the resolution of inflammation, highlighting that balance—not suppression—is critical.

In the brain, arachidonic acid contributes to neuronal membrane structure, synaptic plasticity, and the formation of endocannabinoids involved in mood regulation, cognition, and stress responses. Both excessively low and excessively high AA availability may negatively affect neurological function, underscoring the importance of optimal—not minimal—levels.

Crucially, arachidonic acid does not act in isolation. It competes directly with omega-3 fatty acids (EPA and DHA) for the same metabolic enzymes. When omega-3 intake is low, AA metabolism dominates, tilting signaling toward pro-inflammatory pathways. When omega-3 intake is adequate, EPA and DHA generate competing mediators that dampen excessive inflammation and promote resolution. Therefore, arachidonic acid levels and their health impact must always be interpreted in the context of overall fatty acid balance, rather than as a standalone marker.

Dietary factors are the primary driver of arachidonic acid levels. AA is found almost exclusively in animal-derived foods, with highest concentrations in red meat, poultry, eggs (especially yolks), and full-fat dairy. High intake of linoleic acid—from vegetable oils such as soybean, sunflower, safflower, and corn oil—can also increase AA levels indirectly by providing more substrate for conversion. Diets high in ultra-processed foods often deliver both high linoleic acid and low omega-3 intake, amplifying AA-dominant signaling.

Lifestyle factors influence AA metabolism rather than intake alone. Chronic psychological stress, poor sleep, smoking, and physical inactivity increase inflammatory signaling and can amplify AA-derived mediator production. Regular physical activity, on the other hand, supports healthier inflammatory regulation and lipid metabolism.

Related biomarkers include linoleic acid, dihomo-γ-linolenic acid (DGLA), omega-3 fatty acids (EPA and DHA), inflammatory markers such as C-reactive protein (CRP), and lipid markers such as triglycerides and LDL cholesterol. These help contextualize whether elevated AA reflects dietary excess, metabolic dysfunction, or insufficient omega-3 counterbalance.

Micronutrient status also matters. Enzymes involved in AA metabolism require adequate zinc, magnesium, iron, vitamin B6, and niacin. Antioxidants such as vitamin E, vitamin C, selenium, and polyphenols help protect polyunsaturated fats from oxidative damage, which can otherwise worsen inflammatory signaling.

Environmental influences, including exposure to air pollution, endocrine-disrupting chemicals, and other toxins, can up-regulate inflammatory pathways and alter fatty acid metabolism, indirectly increasing the biological impact of arachidonic acid.

Unit: Red blood cell membranes, % of total fatty acids

• Optimal: 13.0–17.0%

• Mildly high: 17.1–19.0%

• Very high: >19.0%

• Low: <12.9%

Your results are high

If your arachidonic acid levels are elevated, this suggests a shift toward more pro-inflammatory fatty acid signaling.

Diet:

• Focus on reducing frequent intake of AA-rich foods such as red meat, processed meats, and egg yolks, while prioritising omega-3-rich foods.

• Aim for 2–3 servings of fatty fish per week (e.g., salmon, sardines, mackerel) and use extra-virgin olive oil instead of seed oils for cooking.

Lifestyle:
Engage in regular moderate exercise (at least 150 minutes per week), prioritise sleep consistency, and incorporate stress-management practices to reduce inflammatory drive.

Supplements:
Omega-3 supplements providing EPA and DHA may help rebalance fatty acid signaling when dietary intake is insufficient.

Additional tests:

• Inflammatory markers (CRP)

• full fatty acid profile

• standard lipid markers can help assess cardiometabolic context. Medical supervision is recommended if inflammatory markers are persistently elevated

Your results are low

Low arachidonic acid may indicate insufficient dietary intake or impaired fatty acid metabolism.

Diet:

• Ensure adequate intake of AA-containing foods such as eggs, poultry, or meat, especially if following a very low-fat or plant-based diet.

• Include sources of linoleic acid in moderation to support endogenous synthesis.

Lifestyle:
Maintain balanced energy intake and overall nutritional adequacy to support membrane health and hormone signaling.

Supplements:
Targeted AA supplementation may be considered in specific cases (e.g., strict plant-based diets), ideally with professional guidance.

Additional tests:

• Assessment of linoleic acid

• omega-3 levels

• micronutrients such as zinc and magnesium can help identify contributing factors

1. Tallima H, El Ridi R. Arachidonic acid: physiological roles and potential health benefits. Journal of Advanced Research. 2018;11:33–41. doi:10.1016/j.jare.2017.11.004.

2. Das UN. Essential fatty acids and their metabolites in the pathobiology of inflammation and its resolution. Biomolecules. 2021;11(12):1873. doi:10.3390/biom11121873.

3. Kaviani E, Hajibabaie F, Abedpoor N, Safavi K. Synergic effects and possible mechanisms of omega-6 fatty acids on immune function, inflammation, and cancer. Molecular Nutrition & Food Research. 2025;69(12):e70092. doi:10.1002/mnfr.70092.

4. Badimon L, Vilahur G, Rocca B, Patrono C. The contribution of platelet and vascular arachidonic acid metabolism to the pathophysiology of atherothrombosis. Cardiovascular Research. 2021;117(9):2001–2015. doi:10.1093/cvr/cvab003.

5. Schulze MB, Minihane AM, Saleh RNM, Risérus U. Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases. The Lancet Diabetes & Endocrinology. 2020;8(11):915–930. doi:10.1016/S2213-8587(20)30148-0.

6. Simopoulos AP. Evolutionary aspects of diet, the omega-6/omega-3 ratio, and genetic variation: nutritional implications for chronic diseases. Biomedicine & Pharmacotherapy. 2006;60(9):502–507. doi:10.1016/j.biopha.2006.07.080.

7. MacIntosh BA, Ramsden CE, Faurot KR, et al. Low-omega-6 and low-omega-6 plus high-omega-3 diets for use in clinical research. British Journal of Nutrition. 2013;110(3):559–568. doi:10.1017/S0007114512005181.

8. Drobner T, Braun TS, Kiehntopf M, et al. Influencing factors on metabolism of plant-derived omega-3 polyunsaturated fatty acids: the KoALA study. Nutrients. 2023;15(20):4461. doi:10.3390/nu15204461.